Stockscreener 앱 받기
19.54
2.84%
0.54
시간 외 거래:
19.54
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Amphastar (AMPH) EVP Yakob has 1,033 shares withheld for RSU tax - Stock Titan
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Tax withholding trims Amphastar (NASDAQ: AMPH) exec's RSU shares - Stock Titan
Tax withholding on RSU vesting for Amphastar (AMPH) CFO Peters - Stock Titan
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - TradingView
Amphastar Pharmaceuticals Inc authorizes $50 million increase to share buyback program on March 12, 2026SEC filing - marketscreener.com
Amphastar Pharmaceuticals IncAuthorizes $50 Million Increase To Share Buyback Program On March 12, 2026SEC Filing - TradingView
Amphastar Expands Share Repurchase Authorization to Manage Equity - TipRanks
Amphastar Pharmaceuticals boosts buyback program by $50 million - TradingView
Amphastar (NASDAQ: AMPH) adds $50 million to share buyback program - Stock Titan
Clark Capital Management Group Inc. Invests $7.56 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Algert Global LLC Acquires 268,612 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Amphastar reports FDA approval for teriparatide injection - MSN
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare ConferenceSlideshow - Seeking Alpha
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowShould You Sell? - MarketBeat
Amphastar (AMPH) CFO granted RSUs, stock options and withholds shares for taxes - Stock Titan
Risk Report: Can Amphastar Pharmaceuticals Inc maintain its current growth rateRate Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Amphastar (AMPH) exec granted RSUs, options and reports tax share withholding - Stock Titan
Amphastar (NASDAQ: AMPH) EVP receives RSUs and stock option grant - Stock Titan
Equity awards and tax withholding for Amphastar Pharmaceuticals (AMPH) insiders - Stock Titan
Amphastar (AMPH) CFO Peters reports 2,146-share tax-withholding on RSU vesting - Stock Titan
Amphastar (AMPH) CEO logs 10,850-share RSU tax withholding, retains large stake - Stock Titan
Amphastar Pharmaceuticals : Barclays 28th Annual Global Healthcare Conference Presentation - marketscreener.com
AMPH SEC FilingsAmphastar Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Shorts: Can Amphastar Pharmaceuticals Inc maintain its current growth rateJuly 2025 Price Swings & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Can Amphastar Pharmaceuticals Inc. stock reach $100 price targetIPO Watch & Daily Profit Maximizing Trade Tips - Naître et grandir
Risk Check: Is Amphastar Pharmaceuticals Inc a potential multi baggerGold Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
Vanguard Group Inc. Has $70.12 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals signs new executive employment agreements By Investing.com - Investing.com UK
Generic Pharmaceuticals Q4 2025 Review: Revenue Beat, Stock DeclineNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Amphastar Pharmaceuticals signs new executive employment agreements - Investing.com UK
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Amphastar Updates Executive Employment Agreements to Strengthen Leadership - TipRanks
Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3SEC Filing - TradingView
Family-linked China partners sign new Amphastar (NASDAQ: AMPH) deals - Stock Titan
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), Amphastar Pharmaceuticals Inc has signed a five-year supply agreement, under which all payments will be settled in RMB. - Bitget
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks - TipRanks
Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH) - Finviz
Amphastar Pharmaceuticals Hits Day Low of $19.83 Amid Price Pressure - Markets Mojo
Amphastar Pharmaceuticals Stock Plummets to New 52-Week Low of $19.83 - Markets Mojo
Royce & Associates LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference - ACCESS Newswire
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Potential Upside of 38% Attracts Investor Attention - DirectorsTalk Interviews
Wells Fargo Sees Amphastar Pharmaceuticals, Inc.'s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth - Finviz
Wells Fargo Sees Amphastar Pharmaceuticals, Inc.’s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth - Yahoo Finance
Cash per share of Amphastar Pharmaceuticals, Inc. – DUS:29A - TradingView
Amphastar FDA Wins And Pipeline Expansion Contrast With Weak Earnings And Valuation - Yahoo Finance
Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2025 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Stock Hits New 12-Month Low After Analyst Downgrade - National Today
AMPH Stock (-24%): Q4 Earnings Miss Sparks Aggressive Liquidation - Trefis
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low After Analyst Downgrade - MarketBeat
Amphastar Pharmaceuticals Q4 2025 Report: Revenue Miss, Stock DeclineNews and Statistics - IndexBox
Amphastar stock hits 52-week low at $20.38 By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results - MarketBeat
Amphastar Pharmaceuticals Inc (29A.BE) Stock Price, News, Quote & History - Yahoo Finance
Amphastar stock hits 52-week low at $20.38 - Investing.com
TD Asset Management Reduces Stake in Amphastar Pharmaceuticals - National Today
2.02%
0.77%
자본화:
|
볼륨(24시간):